Altre lingue Dr. Lal PathLabs Limited

Azioni

LALPATHLAB

INE600L01024

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:40:30 16/07/2024			Variaz. 5gg	Var. 1 gen.
2.998 ^INR	+0,04%		+3,15%	+16,31%

29/06	Dr. Lal PathLabs Limited dichiara il dividendo finale per l'anno finanziario conclusosi il 31 marzo 2024	CI
14/05	DR. LAL PATHLABS LIMITED : il giudizio da Nomura è ora al rialzo	ZM

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Dr. Lal PathLabs Limited Declares Final Dividend for the Financial Year Ended March 31, 2024	29/06
Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	13/05
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10/05
Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	10/05
Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10/05
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	26/04
Dr Lal Pathlabs Names CEO	18/03
Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024	17/03
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer	03/03
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	02/02
Dr. Lal PathLabs Seeks M&A	01/02
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	01/02
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/02
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	25/01
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	03/11
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	12/09/23
Dr. Lal PathLabs Limited Announces Change in Directorate	20/08/23
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	31/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Dr. Lal PathLabs Limited

Azioni

LALPATHLAB

INE600L01024

Altre lingue

Filtri